URINARY-EXCRETION OF NORADRENALINE AFTER TREATMENT WITH ALPHA-METHYLDOPA - INHIBITION BY A CENTRAL NERVOUS MECHANISM

被引：4

作者：

ANDEN, NE ^{[1
]}

HENNING, M ^{[1
]}

机构：

[1] UNIV GOTHENBURG,DEPT PHARMACOL,GOTHENBURG,SWEDEN

来源：

ACTA PHYSIOLOGICA SCANDINAVICA | 1974年 / 90卷 / 01期

关键词：

D O I：

10.1111/j.1748-1716.1974.tb05563.x

中图分类号：

Q4 [生理学];

学科分类号：

071003 ;

摘要：

引用

页码：69 / 72

页数：4

共 14 条

[1] CENTRAL DECARBOXYLATION AND UPTAKE OF L-DOPA [J].

ANDEN, NE ;

ENGEL, J ;

RUBENSON, A .

NAUNYN-SCHMIEDEBERGS ARCHIV FUR PHARMAKOLOGIE, 1972, 273 (1-2) :11-&

[2] A METHOD FOR THE FLUORIMETRIC DETERMINATION OF ADRENALINE AND NORADRENALINE IN TISSUES [J].

BERTLER, A ;

CARLSSON, A ;

ROSENGREN, E .

ACTA PHYSIOLOGICA SCANDINAVICA, 1958, 44 (3-4) :273-292

[3] IN-VIVO DECARBOXYLATION OF ALPHA-METHYL DOPA AND ALPHA-METHYL METATYROSINE [J].

CARLSSON, A ;

LINDQVIST, M .

ACTA PHYSIOLOGICA SCANDINAVICA, 1962, 54 (01) :87-&

[4]

DAVIS RUTH A., 1963, LIFE SCI, V3, P193

[5]

EULER US, 1956, NORADRENALINE

[6] ACTIONS OF THE DECARBOXYLASE INHIBITOR, ALPHA-METHYL-3,4-DIHYDROXYPHENYLALANINE, IN THE DOG [J].

GOLDBERG, LI ;

DACOSTA, FM ;

OZAKI, M .

NATURE, 1960, 188 (4749) :502-504

[7]

HENNING M, 1969, ACTA PHARMACOL TOX, V27, P135

[8] BLOOD PRESSURE AND NORADRENALINE LEVELS AFTER TREATMENT WITH ALPHA-METHYLDOPA ALPHA-METHYLDOPAMINE AND ALPHA-METHYL-M-TYROSINE [J].

HENNING, M .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 1967, 19 (11) :775-&

[9]

LEDUC J, 1961, ACTA PHYSIOL SC S183, V53

[10] EFFECTS OF REST AND PHYSICAL ACTIVITY ON URINARY EXCRETION OF NORADRENALINE AND ALPHA-METHYLNORADRENALINE IN HUMAN SUBJECTS TREATED WITH ALPHA-METHYLDOPA [J].

LINDMAR, R ;

MUSCHOLL, E ;

RAHN, KH .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1968, 2 (04) :317-&

← 1 2 →